Developing new methods to create important sugar compounds for medicine
Strategic Molecular Activations for the Selective Synthesis of 2-Deoxy-Beta-Glycosides, and for the Synthesis of Novel Donor-Acceptor Stenhouse Adducts
This study is working on finding better ways to create important sugar compounds that play a role in our health, which could help scientists develop new treatments for various diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11034570 on NIH RePORTER |
What this research studies
This research focuses on improving the synthesis of 2-deoxy-β-glycosides, which are important sugar compounds in biological systems. By using innovative chemical techniques, the team aims to create more effective methods for glycosylation reactions, which are essential for understanding the role of sugars in health and disease. The approach involves using specialized catalysts to enhance the reactivity of sugar donors and acceptors, making the synthesis process more efficient and predictable. This could lead to advancements in the development of new therapies and treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in the biochemical roles of carbohydrates and their potential therapeutic applications.
Not a fit: Patients who are not focused on biochemical research or do not have conditions related to carbohydrate metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments by improving our understanding of how sugars function in biological processes.
How similar studies have performed: Other research has shown promise in developing new glycosylation methods, indicating that this approach could lead to significant advancements in the field.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Picazo, Elias — University of Southern California
- Study coordinator: Picazo, Elias
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.